Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03959748

DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL

The BNP-PL is a multicenter, observational study in which patients are prospectively followed in order to investigate clinical course and management of pulmonary hypertension in Poland.

All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed in right heart catheterization, will be eligible to participate in the study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

3 month and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Krakowski Szpital Specjalistyczny im. Jana Pawła II

Krakow, 31-202, Poland

Location status: Recruiting

Location contact

Grzegorz Kopeć

CONTACT

[email protected]

+48 126143399

About this study

The BNP-PL Registry is an initiative of the Polish Cardiac Society Task Force for Pulmonary Vascular Diseases This study is conducted by the Polish Cardiac Society. All centers of pulmonary hypertension in Poland which are accredited by the National Health Fund have been invited to join the study. The data is administrated by the Jagiellonian University Medical College on the basis of an agreement between the Polish Cardiac Society, Jagiellonian University Medical College and pulmonary hypertension centres.

The goal is to describe current practice and outcomes in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

The data collection will have no impact on the way the patient is diagnosed and treated.

Collection of data on patients with pulmonary hypertension is carried out via the electronic platform.

No personal data is entered into the project database.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed after 1st March 2018 (incident cases) who:

  • are aged > 3 months at the time of enrollment
  • fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods.

Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed before 1st March 2018 (prevalent cases) who:

  • are aged > 3 months at the time of enrollment
  • fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: Since enrollment until at least 5 years.

    The number of patients who die during the follow-up period

Study contacts

Contact information is provided by the study sponsor or research team.

Grzegorz Kopeć

CONTACT

[email protected]

+48 12 614 33 99

Magdalena Studnicka

CONTACT

[email protected]

+48 602460707

Sponsors and collaborators

Lead sponsor

Polish Cardiology Association

Other

Collaborators

  • Jagiellonian University

Registry information

Acronym: BNP-PL

Important dates

Study start
2018
Primary completion
2023
Study completion
2028
First posted
May 22, 2019
Registry last updated
May 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.